ABCL
Price
$4.47
Change
+$0.10 (+2.29%)
Updated
Aug 27, 11:11 AM (EDT)
Capitalization
1.31B
76 days until earnings call
ABSI
Price
$2.54
Change
-$0.00 (-0.00%)
Updated
Aug 27, 01:41 PM (EDT)
Capitalization
381.28M
70 days until earnings call
Interact to see
Advertisement

ABCL vs ABSI

Header iconABCL vs ABSI Comparison
Open Charts ABCL vs ABSIBanner chart's image
AbCellera Biologics
Price$4.47
Change+$0.10 (+2.29%)
Volume$653
Capitalization1.31B
Absci
Price$2.54
Change-$0.00 (-0.00%)
Volume$5.55K
Capitalization381.28M
ABCL vs ABSI Comparison Chart in %
Loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ABSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABCL vs. ABSI commentary
Aug 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Buy and ABSI is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 27, 2025
Stock price -- (ABCL: $4.37 vs. ABSI: $2.55)
Brand notoriety: ABCL and ABSI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 54% vs. ABSI: 52%
Market capitalization -- ABCL: $1.31B vs. ABSI: $381.28M
ABCL [@Biotechnology] is valued at $1.31B. ABSI’s [@Biotechnology] market capitalization is $381.28M. The market cap for tickers in the [@Biotechnology] industry ranges from $99.27B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileABSI’s FA Score has 0 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • ABSI’s FA Score: 0 green, 5 red.
According to our system of comparison, ABCL is a better buy in the long-term than ABSI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 4 TA indicator(s) are bullish while ABSI’s TA Score has 3 bullish TA indicator(s).

  • ABCL’s TA Score: 4 bullish, 3 bearish.
  • ABSI’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, ABCL is a better buy in the short-term than ABSI.

Price Growth

ABCL (@Biotechnology) experienced а +1.86% price change this week, while ABSI (@Biotechnology) price change was -2.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.95%. For the same industry, the average monthly price growth was +13.88%, and the average quarterly price growth was +31.15%.

Reported Earning Dates

ABCL is expected to report earnings on Nov 11, 2025.

ABSI is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+3.95% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABCL($1.31B) has a higher market cap than ABSI($381M). ABCL YTD gains are higher at: 49.147 vs. ABSI (-2.672). ABSI has higher annual earnings (EBITDA): -100.08M vs. ABCL (-197.92M). ABCL has more cash in the bank: 553M vs. ABSI (117M). ABSI has less debt than ABCL: ABSI (7.41M) vs ABCL (142M). ABCL has higher revenues than ABSI: ABCL (32.9M) vs ABSI (4.14M).
ABCLABSIABCL / ABSI
Capitalization1.31B381M343%
EBITDA-197.92M-100.08M198%
Gain YTD49.147-2.672-1,839%
P/E RatioN/AN/A-
Revenue32.9M4.14M795%
Total Cash553M117M473%
Total Debt142M7.41M1,916%
TECHNICAL ANALYSIS
Technical Analysis
ABCLABSI
RSI
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
86%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
81%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 6 days ago
77%
Bullish Trend 15 days ago
90%
Declines
ODDS (%)
Bearish Trend 8 days ago
85%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
86%
Aroon
ODDS (%)
Bullish Trend 1 day ago
70%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ABSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PFHO1.180.09
+8.06%
Pacific Health Care Organization, Inc.
ILKAY20.980.34
+1.65%
Iluka Resources Ltd.
LRLCY92.620.67
+0.73%
L'Oreal Co.
KNNGF52.55N/A
N/A
KION GROUP AG
BPKKF5.80N/A
N/A
BP Castrol KK

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with RXRX. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
+3.31%
RXRX - ABCL
58%
Loosely correlated
N/A
CRSP - ABCL
56%
Loosely correlated
+1.39%
VCYT - ABCL
56%
Loosely correlated
-1.62%
BEAM - ABCL
53%
Loosely correlated
+1.22%
ABSI - ABCL
53%
Loosely correlated
+0.39%
More